Concepedia

Manuel Torres-Diz

MT

Statistics

Publications

10

Citations

458

H-Index

10

Active since

2013

Affiliations

Children's Hospital of Philadelphia(Current)

University of Pennsylvania

Institut d'Investigació Biomédica de Bellvitge

Institució Catalana de Recerca i Estudis Avançats

Josep Carreras Leukaemia Research Institute

Manuel Torres-Diz is an author at Children's Hospital of Philadelphia specializing in molecular oncology, oncology, and life sciences.

ORCID

Publications per year

2013–2024

10

Publications

10

<i>MAX</i> Inactivation in Small Cell Lung Cancer Disrupts MYC–SWI/SNF Programs and Is Synthetic Lethal with BRG1

Octavio A. Romero, Manuel Torres-Diz, Eva Pros et al. · Cancer Discovery · 2013 · 176 citations

, , +17

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance

Mariela Cortés-López, Laura Schulz, Claudia Paret et al. · Nature Communications · 2022 · 59 citations · Full text

, , +15

Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma

Paula Llabata, Yoichiro Mitsuishi, Peter S. Choi et al. · Molecular Cancer Research · 2019 · 53 citations · Full text

, , +16

Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies

Zhiwei Ang, Luca Paruzzo, Katharina E. Hayer et al. · Blood · 2023 · 44 citations · Full text

, , +17

Direct long-read RNA sequencing identifies a subset of questionable exitrons likely arising from reverse transcription artifacts

Laura Schulz, Manuel Torres-Diz, Mariela Cortés-López et al. · Genome biology · 2021 · 39 citations · Full text

, , +17

1–5 of 10